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Abstract 
Skin and soft tissue infections (SSTI’s) are a significant health concern with serious potential 
implications. Evidence suggests the importance of implementing a severity stratification tool to 
improve early identification of SSTI’s. The aim of this evidence based project is to examine if 
educating healthcare staff on the use of a severity stratification tool would increase staff 
knowledge of SSTI's. The sample consisted of 18 participants, 12 healthcare providers and 6 
healthcare staff at a correctional facility in the Southwestern United States. A pre-and posttest 
design, including an educational session was implemented. A 14-item multiple choice self-
developed questionnaire was used to evaluate participants’ knowledge of identifying and ranking 
SSTI’s using the CREST tool. A one tail paired t-test was performed to compare the pre-and 
post-test case study scores for the healthcare provider group. A significant increase from pre-test 
to post-test case study scores was found (t(13)= -6.19, p < 0.00). Of the healthcare providers, 
57% found the tool “moderately helpful.” Of the non-provider sample, 50% found the tool 
“extremely helpful” and plan to use the tool “all of the time.” The findings of this study suggest 
that implementing an educational session on a wound severity stratification tool improves staff 
knowledge and increases the likelihood of the tool being used in practice. Recommendations for 
future research include larger sample sizes across a variety of regional correctional facilities to 
further explore the use and knowledge of the tool in practice.  
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Skin and Soft Tissue Infections: Using a Severity Stratification Tool to Improve Knowledge 
The incidence of primary care visits for skin and soft tissue infections (SSTI’s) have 
substantially increased over recent years. This is of greater significance in high-risk patient 
populations, such as immune compromised patients and inmates. Not only have SSTI’s 
increased, but also the emergence of Methicillin Resistant Staphylococcus Aureus (MRSA) has 
further complicated this issue. SSTI’s have had severe economic and health status consequences 
that impact healthcare resources, patient safety and quality of care.  
Problem Statement 
Skin and soft tissue infections (SSTI’s) have presented problems for primary care patients 
in recent years. SSTI’s account for nearly 14 million primary care visits each year in the United 
States (U.S.), and this statistic has been climbing in the last decade (Ramakrishan, Salinas & 
Higuita, 2015; Ray, Suaya & Baxter, 2013). Skin and soft tissue infections originate from a 
bacterial invasion of the skin, resulting in a variety of skin presentations (Ramakrishan, Salinas 
& Higuita, 2015; Lee et al., 2016). These particular presentations can be classified as either 
simple (involving superficial tissue) or complicated (involving deep tissues) SSTI’s. Common 
simple SSTI’s include cellulitis, impetigo, folliculitis, furuncles, carbuncles and abscesses. 
Complicated SSTI’s include necrotizing fasciitis, gangrene and infections of animal or human 
bites (Ramakrishan, Salinas & Higuita, 2015; Ray, Suaya & Baxter, 2013).   
The emergence of Methicillin Resistant Staphylococcus Aureus (MRSA) has further 
complicated the incidence of skin and soft tissue infections. MRSA is a gram-positive cocci 
bacterium that presents as a break in the skin, abscess or boil that has become resistant to 
standard antimicrobial treatment (Lee et al., 2016). In the United States, approximately 80-90% 
of SSTI’s are found to contain the bacterium MRSA (Lee et al., 2016; Mullen & O’Keefe, 2015). 
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SSTI’s affect all populations, but an increased incidence has been seen in high-risk patients, 
which includes correctional facility inmates (Mullen & O’Keefe, 2015). The rise of MRSA in 
correctional facilities in the U.S. over the last decade has caused great concern not only for 
inmates and correctional staff, but when individuals are released from prison back into society 
(Mullen & O’Keefe, 2015). The number of incarcerated individuals in the United States has 
increased by 300% since 1980, increasing the risk of acquiring MRSA in correctional facilities, 
but also in the community upon release (Mullen & O’Keefe, 2015). 
Purpose and Rationale 
 Skin and soft tissue infections are a significant health concern with serious potential 
implications that can affect health status of communities and impact the healthcare system 
through increased emergency room visits and hospitalizations related to complicated SSTI’s (Lee 
et al., 2016; Ramakrishan, Salinas & Higuita, 2015; Ray, Suaya & Baxter, 2013). If an SSTI 
goes untreated or treatment is delayed due to difficult diagnostic accuracy the condition may 
progress to sepsis, deformity, skin grafts, necrotizing fasciitis, limb amputation or even death 
(Lee et al., 2016; Ramakrishan, Salinas & Higuita, 2015; Ray, Suaya & Baxter, 2013). In 2005, 
nearly 11,406 people died of MRSA infections in the U.S. (Mullen & O’Keefe, 2015). This is 
more than the number of people in the U.S. that died of Acquired Immune Deficiency Syndrome 
(AIDS) in that same year (Mullen & O’Keefe, 2015).  
SSTI’s also pose a significant financial burden. The annual cost of community acquired 
MRSA is 478 million to 2.2 billion U.S. dollars (Lee et al., 2013). This impacts the U.S. 
department of corrections (DOC) as 15 to 36 million U.S. dollars are spent annually in the 
American jail system on costs related to MRSA alone (Lee et al., 2013). By exploring the root 
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cause of the increased incidence of SSTI’s, one can explore potential interventions to decrease 
the occurrence and severity of SSTI’s in the community and correctional setting.  
Background/Significance 
 An emergence of SSTI’s, specifically MRSA, has been seen in distinct patient 
populations that include: athletic teams, students in dormitories, military recruits, the homeless 
population and the incarcerated (Malcolm, 2011). Overall though, the correctional facility inmate 
population is at an even higher risk of MRSA then other population groups. Many of the 
potential risk factors for SSTI’s and MRSA often directly correlate with this subgroups personal 
demographics and residential setting (Malcolm, 2011; Mullen & O’Keefe, 2015). Factors such as 
overcrowded living conditions, outdoor work assignments, self-draining of abscesses, sharing 
soap, washing clothes by hand and close contact with persons known to have MRSA contribute 
to the incidence and prevalence of this condition. Additional co-morbid health related issues 
include obesity, diabetes mellitus and inadequate hygiene (Malcolm, 2011; Mullen & O’Keefe, 
2015; Ray, Suaya & Baxter, 2013). In a three-year study of predictors of SSTI’s, authors Ray, 
Suaya and Baxter (2013) determined that of the 376,262 patients studied with SSTI’s, 50% had a 
diagnosis of diabetes mellitus.  
Additionally, inmates generally have a higher incidence of past intravenous (IV) drug 
use, alcohol abuse, prison tattoos, Human Immunodeficiency Virus (HIV), Hepatitis B, Hepatitis 
C and tuberculosis, which are also high-risk factors for MRSA (Mullen & O’Keefe, 2015; 
Ramakrishnan, Salinas & Higuita, 2015). Recent research demonstrates a correlation between 
age, MRSA risk factors, and SSTI (Malcolm, 2011; Ramakrishnan, Salinas & Higuita, 2015). In 
a study of correctional inmates, authors found that inmates ages 30-49 years were significantly 
more likely to have MRSA infections than patients less than 29 or patients over the age of 50 
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(Malcolm, 2011). There is no known cause for this increase in the prevalence of MRSA in ages 
30 to 49 years of age (Malcolm, 2011; Ramakrishnan, Salinas & Higuita, 2015).  
 Despite preventative efforts, the incidence of SSTI’s continues to escalate, and treatment 
failure is widespread (Lee et al., 2016; Miller et al., 2015; Suaya et al., 2014). Potential barriers 
to restrain this trend include a lack of standardized polices, screening and education. Research 
demonstrates that a primary barrier is a lack of standardized policies or tools for early diagnosis 
and treatment of SSTI’s (Flanagan, 2014; Marwick, 2011; Mullen & O’Keefe, 2015; Talan et al., 
2014). Wound management is often an area of expert opinion versus evidence-based practice, 
making it difficult to formulate policies and standardized tools (Flanagan, 2014). The signs and 
symptoms of SSTI’s can be masked or vague, making proper diagnosis difficult (Tiwari & Lal, 
2014). SSTI’s also can be difficult to diagnose related to their considerable variability and 
severity (Hashem, Hidayat, Berkowitz, & Venugopalan, 2016; Tiwari & Lal, 2014). In 2005, the 
Infectious Disease Society of America (IDSA) developed guidelines for MRSA infection 
treatment (Stevens et al, 2014). These guidelines were then updated by IDSA in 2014, but still no 
other guidelines have been produced for SSTI’s in general and the actual implementation of 
these guidelines in primary care is lacking (Stevens et al., 2014).  
Inadequate education, screening and standardized policies have been noted in 
correctional facilities across the U.S. (Malcolm, 2011; Mullen & O’Keefe, 2015). In a study of a 
correctional facility in Omaha, Nebraska researchers discovered the facility to be deficient in a 
specific treatment policy and guideline for MRSA SSTI’s (Mullen & O’Keefe, 2015).  The 
authors created and implemented a screening and treatment policy for 132 inmates with MRSA 
SSTI (Mullen & O’Keefe, 2015). As a result, by improving the screening and treatment 
procedure for SSTI’s they were able to improve staff education, patient education and patient 
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outcomes (Mullen & O’Keefe, 2015). In another correctional facility in Georgia, after a MRSA 
outbreak staff implemented a multi-modal intervention and noted similar results (Malcolm, 
2011). In this study the authors incorporated interventions to include screening for skin lesions, 
personalized hygiene, antimicrobial therapy, and standardized wound care (Malcolm, 2011). As 
a result, the MRSA rate of infection decreased from 11.6 per 10,000 inmates to 0 per 10,000 
inmates in the post-study period (Malcolm, 2011).  
The management of SSTI’s is primarily related to infection severity, location and patient 
co-morbidities (Ramakrishnan, Salinas & Higuita, 2015; Stevens et al., 2014; Tiwari & Lal, 
2014). Despite this being common practice for management and treatment, there is no 
standardized severity scale for SSTI’s (Tiwari & Lal, 2014). Several studies have tested 
established severity tools for accuracy and reliability. The CREST tool measures severity of 
illness with SSTI’s (Hashem et al., 2016; Marwick, 2011). The CREST tool is based on the Eron 
classifications (Marwick, 2011). In this study, the authors used the CREST hierarchical scoring 
system to measure SSTI severity ranging from one to four, with one being least severe SSTI and 
four being most severe SSTI (Hashem et al., 2016). Through the CREST scoring system, 
researchers were able to accurately ascertain SSTI severity and determine proper antimicrobial 
treatment (Hashem et al., 2016).  Researcher Marwick (2011) also created his own tool based on 
the Eron classification and CREST tool. This tool also used a severity scale of one to four, one 
being least severe SSTI and four being most severe SSTI (Marwick, 2011). The researcher 
looked at appropriate empirical antibiotic treatment of SSTI’s based on the SSTI severity 
classification (Marwick, 2011). Marwick (2011) discovered there to be a lack of consistency in 
antimicrobial treatment strategies. Over 43 different antimicrobials were selected in the treatment 
of SSTI’s in this study (Marwick, 2011).  In another study, the authors looked at using a severity 
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stratification algorithm in formulating treatment strategies for SSTI’s (Tiwari & Lal, 2014). The 
authors created this algorithm and it has not yet been tested in any other studies. The algorithm 
addressed whether the patient has redness, warmth, pain or swelling to wound, signs of sepsis, 
and size of wound. The authors found this algorithm helpful with proper detection of severity 
and subsequent treatment for SSTI’s (Tiwari & Lal, 2014).  
SSTI’s and MRSA also present a significant financial burden to patients, third party 
payers, and health care facilities (Lee et al., 2013; Suaya et al., 2014). In a study of inpatients and 
outpatients with SSTI’s in the United States, the mean annual cost for treatment for a single SSTI 
case was $8,865 (Suaya et al., 2014).  The pharmacological treatment and medical/nursing care 
for MRSA is complicated compared to a SSTI caused by another bacterium. This is reflected in 
the mean cost for treatment for a single case of MRSA-SSTI being estimated at $40,046 U.S. 
dollars (Suaya et al., 2014). The financial burden of SSTI’s have also been recognized in U.S. 
correctional systems. In a study of the financial implications of MRSA and SSTI’s, the 
researchers studied a U.S. correctional facility in Pittsburg (Lee et al., 2013). At Cook County 
correctional facility, the authors determined the annual societal cost of SSTI’s to be $140,275 
U.S. dollars, reflecting not only cost to patients and third-party payers but also to society (Lee et 
al., 2013).  
As a whole, the literature identifies risk factors for skin and soft tissue infections that 
substantiate the high incidence for SSTI’s in the correctional system. These risk factors include: 
overcrowded populations, poor hygiene, IV drug use, alcohol abuse, HIV, Hepatitis B and C, age 
and co-morbid conditions such as diabetes. The literature also identifies barriers to decreasing 
the incidence of SSTI’s, principally the lack of a standardized tool or policy for SSTI 
identification, management and treatment. Thus far, studies have shown that implementing a 
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standardized policy, algorithm or severity rating scale have improved patient outcomes and 
decreased the rate of SSTI’s and MRSA.  
Internal Evidence 
In a county correctional facility in the Southwestern U.S., the incidence and prevalence of 
SSTI’s in this population has been of concern, especially related to MRSA SSTI early 
identification and treatment. Because of the high incidence of MRSA SSTI’s, the organization’s 
healthcare providers no longer culture wounds, but instead presume MRSA and treat skin and 
soft tissue infections accordingly. This correctional facility has no standardized policy or 
algorithm for how nursing staff or medical providers should treat SSTI’s. This inquiry has led to 
the clinically relevant PICOT question: In adults at high risk for skin and soft tissue infections 
how does a risk stratification severity tool compare to usual wound diagnosis, affect time to 
healing and hospitalization rates?  
Search Strategy 
In order to address how a wound severity stratification tool can improve patient outcomes 
an exhaustive search of the literature was undertaken. Databases searched for the literature 
review included PubMed, Elton B Stephens Company host (EBSCO host) and Web of science. 
Keywords searched included: “soft tissue skin infection,” “MRSA,” “correctional facilities,” 
“community acquired” “primary care” and “management.” The following limits were placed: 
Adult population, English language and date limits 2012 to 2017. Date limits were expanded to 
1980 to capture landmark studies. Over 5,000 studies were initially yielded, so then Boolean 
phrases and MESH terms were utilized. Inclusion criteria for the studies included adult 
population and diagnosis of SSTI. Exclusion criteria included studies prior to 2012 (except 
landmark studies) and patients younger than 18 years of age. The MESH terms search method 
SKIN AND SOFT TISSUE INFECTIONS  
 
  
10 
for PubMed yielded 2,402 results (Appendix A). Using MESH term “skin and soft tissue 
infections” and title/abstract keyword “primary care”, the search was further narrowed and four 
of the articles yielded were pertinent to this project. The search was then narrowed to MESH 
term “skin and soft tissue infections” and title/abstract keyword “correctional facilities,” which 
yielded five articles. Using hand search, other references to other articles were found. These 
studies contained “MRSA” in their title. So a search was done for MESH term “MRSA” and 
title/abstract keyword “correctional facilities” yielding three results pertinent to the topic of 
interest.  
The Boolean phrase term search for SSTI on EBSO host yielded 4,628 studies (Appendix 
B). By using connected Boolean phrases results yielded were narrowed down to 727 when 
combined terms of “MRSA” and “community acquired” were used. At this time, the search was 
still yielding a large quantity of unrelated studies. Boolean phrases were then used for “MRSA” 
and “management”, which resulted in 288 studies. Then “MRSA” and “correctional facility” was 
searched which resulted in 14 studies. Two selected studies were repeated in above search of 
PubMed, but the search also yielded one new study pertinent to topic. This study was a landmark 
study and outside of 5-year date inclusion criteria. Web of science search for key word “soft 
tissue skin infection” yielded 731 results (Appendix C). These results were then narrowed adding 
“management” to current search, which resulted in 54 studies. Of these 54 studies three met 
inclusion criteria for this topic. Roughly 20 articles were initially reviewed for inclusion, but 10 
were ruled out due to poor documentation, inconclusive evidence, weak descriptive or statistical 
data, misleading conclusions or impertinent data or results. The ten studies that were chosen for 
inclusion met the criteria and were relevant to the stated PICO question. Each study was 
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reviewed and the data was extracted and organized in an evidence table for examination 
(Appendix D). 
Evidence Synthesis 
 Ten studies have been chosen for inclusion in this literature review. All studies were 
evaluated using rapid critical appraisal and were placed in evaluation and synthesis tables 
(Appendix D, Appendix E). Overall, the strength of the studies were moderate, encompassing six 
level II evidence and four with level III evidence, in which three were retrospective cohort 
studies, one observational cross-sectional study, and five prospective cohort studies (Appendix 
D). The stated PICOT question was better answered by retrospective and prospective studies, 
resulting in lower levels of evidence. However the ten included studies were substantiated by 
statistically significant results (Appendix D). None of the studies stated theoretical frameworks 
or models, but they were implied. A large majority of these implied models, focused on 
prevention models to include: Levels of prevention model and Millio’s prevention framework. 
All articles required a diagnosis of SSTI’s. Very few of the studies listed specificities or 
sensitivities for their measuring instruments, but the majority of the studies used some form of a 
risk stratification severity ranking system adopted for SSTI’s (Appendix D). This is suspected 
due to no formally accepted severity scale of SSTI’s yet. Reliability and validity of these tools 
was identified in six of the articles, showing statistical significance in using risk scales to reduce 
poor patient outcomes (Appendix E). Possible bias was noted in three of the studies, all three of 
which were funded by Pharmaceutical companies, but when researching these companies further 
none of the antimicrobial treatment options utilized in these studies appeared to be their products 
(Appendix D). Seven of the studies took place in hospital settings and the remaining three studies 
took place in community settings. The selection of hospital settings appears to be related to 
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current research focusing on causation and risk factors of SSTI’s in hospital admissions. 
Additionally, five of the studies took place in Europe and five took place in the U.S. Since the 
CREST tool was created in Scotland, it is more highly utilized in Europe currently. Homogeneity 
was present in demographic data. A large proportion of the studies saw an association between 
increased age and comorbidities, resulting in poor patient outcomes. Patient outcomes were 
measured across the studies as increased time to healing, death, re-occurrence of SSTI or re-
hospitalization (Appendix E). Several studies incorporated the CREST scoring or the authors 
own adaptation of it. Overall the studies found the variables lesion size, fever and duration of 
skin infection to be the most significant in determining the severity of the infection when using 
the tool (Appendix D). Heterogeneity of the studies was noted especially in the selection of a 
severity stratification tool. The studies used a variety of severity stratification tools. Some of the 
studies used established scoring tools to include CREST, SEWS and Ki/Rothstein, while others 
developed modified severity scoring tools or risk stratifications (Appendix E). Across the studies 
though, all of the tools were shown to be statistically significant in improving utilization of 
appropriate antimicrobial treatment measures and to improve patient outcomes.  
Current practice in the identification and management of SSTI’s is inconsistent with 
evidence based practice guidelines. Evidence suggests the importance of implementing a severity 
stratification tool to improve early identification of SSTI’s, which in turn can improve long-term 
patient outcomes. The research does not show evidence of one severity tool being highly 
accurate over another, but the research collectively shows any severity tool utilized in SSTI 
identification and treatment, results in improved patient outcomes. Although, the CREST tool 
was the most frequently used tool and had more robust research compared to the other severity 
stratification tools. A severity stratification tool is a quick, easy and low-cost item to prevent 
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hospitalizations, surgical interventions and mortality related to SSTI’s. The proposed evidence 
based project includes educating healthcare providers and nurses, in a Southwestern correctional 
facility on the use of the CREST tool in an effort to increase staff knowledge of proper 
identification and treatment of SSTI's, and for healthcare staff to have an increased rate of use of 
this tool in their practice.  
Conceptual Framework and EPB Model 
Implementation of an SSTI severity stratification tool focuses on early detection to 
prevent worsening of SSTI disease state. The Models of Prevention theory suits this project 
design (Nilsen, 2015). This model emphasizes the idea that health is on a continuum, with health 
at one end and advanced disease on the other. The model uses three levels of application of 
preventative measures that can be used to promote health and stop the disease at different points 
along the continuum. This continuum has four levels: primordial, primary, secondary and tertiary 
(Nilsen, 2015). Secondary and tertiary levels would be appropriate for the severity stratification 
tool for SSTI’s, given the SSTI is already established and the goal is early identification and 
treatment, to prevent increased severity of disease.  
The evidence based model (EBP) Advancing Research and Clinical Practice through 
Close Collaboration (ARCC) facilitated the proposed practice change. This model resembles an 
organizational plan for a department (Appendix F). The model first focuses on assessing the 
organizational culture and the readiness for system wide implementation, then on identifying 
organizational barriers and strengths to EBP implementation plan and follow through with 
actually implementing the EBP intervention (Schaffer, M.A., Sandau, K.E. & Diedrick, L., 
2012). This is an appropriate model for a large organization. The organization where the project 
was implemented is resistant to change. Using ARCC one could first evaluate specific barriers 
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staff may have with implementation of this project. One of the nurse practitioners at this facility 
was used as an EBP mentor. Throughout this project, the EBP mentor was utilized in this 
capacity, which is consistent with this model.  
Project Methods 
 Evidence based project approval was obtained through Arizona State University 
Investigation Review Board (IRB) and through facility medical director approval. Participants 
were recruited using flyers, email invitations and word of mouth. Inclusion criteria required the 
participants to be 18 years or older, the ability to read and write the English language and a 
current employee of the identified correctional facility. A consent letter was provided to the 
participants prior to the intervention that included information on the project participation risks 
and benefits. The potential benefits of this project included: potential increase in knowledge 
related to skin and soft tissue infections and a potential increase in self-confidence to assess, 
diagnose and treat skin and soft tissue infections. The only potential risk for participants 
identified was time away from other work duties in order to complete the educational session, 
which could potentially increase work burden. Participants were also aware that they could with 
draw from the project at any time, as it was stated in the consent letter. Additionally, by 
participants completing the educational session it was considered implied consent to participate 
in the project. In order to protect the project participants’ identity, participants selected a unique 
number of their choosing and were instructed to write this number on the top of their pre-test and 
post-test. These unique identifiers functioned to maintain the participants’ privacy, while still 
allowing for pre-and post-test data to be compared.  
 The project setting is an outpatient clinic in a correctional facility in the Southwestern 
U.S. that houses over 2,440 inmates. This facility also houses a 60-bed medical infirmary and a 
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primary care clinic. The outpatient clinic includes over 75 nurses and over 20 healthcare 
providers. This is a site with several barriers to change. Because of inmates being a high-risk 
population, changes to policies and procedures have to go through a stringent and laborious 
process before being implemented in this setting. Also, initially staff and key stakeholders were 
not open to the idea of change. To these staff members, a practice change was viewed as a 
burden to practice.  Because of the many hurdles involved with invoking change at this site, 
resistance to change was expected and occurred initially.   
The final sample size consisted of 18 participants, 12 healthcare providers in the provider 
group and 6 healthcare staff members in the non-provider healthcare group. The intervention 
itself included a pre-and posttest design and an educational session. The interventional sessions 
took place at two separate events in October 2017, one for the healthcare providers at their 
monthly provider meeting and one for the nurses and other healthcare members at their monthly 
educational meeting. At these two meetings, participants were initially provided with the consent 
letter. After reading over the consent letter, participants were given a self-created pre-and post-
test and a severity stratification tool algorithm. The pre-and post-test questionnaires were 
reviewed by faculty for content and validity. The algorithm itself is a self-created tool that 
incorporates the CREST tool into a helpful and easy to use algorithm for healthcare members to 
use for easy identification, assessment and treatment of SSTI’s. This algorithm was determined 
to be a reliable and accurate tool after review by several experts for accuracy. The participants 
were directed to put a unique identifier number at the top of the pre-and post-test and to then 
place the post-test to the side. Prior to the educational session, participants were given fifteen 
minutes to complete the pre-test of knowledge. And after the educational session was complete, 
participants were given fifteen minutes to complete the posttest of knowledge. Both the pre-test 
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and post-test involved questions related to identifying SSTI’s and case study questions. The 
questions were the same on the pre-and post-test, except for three questions on the post-test 
involving if the participant felt the tool was helpful and whether they would use it in practice. 
Additionally, the demographic questions were only on the pre-test, not on the post-test. The 
questions for the provider group versus the non-provider group slightly differed. The non-
provider group case study questions only included questions to identify and assess SSTI’s using 
the CREST tool, whereas the health care provider case study questions included diagnosing and 
treating SSTI’s using the CREST tool. Immediately following the pre-test, a thirty-minute 
educational session was presented to the participants by the project leader using power point 
slides. This power point presentation included information on the background and significance of 
the issue, information on the CREST tool for assessing, diagnosing and treating SSTI’s. 
Participants were also supplied with a copy of the CREST tool algorithm and time was allotted 
for questions or clarifications. Immediately following the educational session, a fifteen-minute 
post-test was administered.  
Since there is currently no instrument specifically focused on improvements in 
knowledge of SSTI’s, a self-developed questionnaire was used. The developed questionnaire is a 
14-item scale, with multiple choice questions. Unanswered questions were treated as incorrect 
answers, and were recorded accordingly. This scale was developed to measure healthcare staff’s 
knowledge of severity rankings of SSTI’s using specifically the CREST tool. The measurement 
includes questions on descriptions of SSTI’s, proper ranking of SSTI’s, participants’ comfort 
level with managing patients with SSTI’s and whether participants plan to use the CREST tool in 
practice. Reliability and validity on this instrument was determined by multiple revisions and 
improvements through feedback from several research and data experts.  
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At the conclusion of the intervention, all pre-and post-test sheets were collected and were 
double checked to ensure the pre-and posttest for each participant had their unique identifying 
number at the top of the tests. These completed pre-and post-tests were then scanned to a 
password protected computer with no participant identifiers on them. Data was manually entered 
into the statistical software SPSS. Questionnaires were broken down into several categories 
based on the multiple-choice questions. Gender, education, license, age was recorded based on a 
Likert scale. The questions on wound characteristics for non-providers and providers were 
broken down into a pre-and post-test category. One point was awarded for each correct question 
for these sections, and these questions were totaled to offer a score. Similarly, for pre-and post-
test case study scores for non-providers versus providers, one point was awarded for each correct 
question and these questions were totaled to offer a score. A Likert scale was used for three 
questions related to usefulness of the tool in practice and actual implementation of the tool in 
practice. This was completed and rechecked by the project lead several times for correct data 
entry and accuracy. It was then further verified for accuracy by the co-investigator and the 
statistical consultant. Descriptive statistics and inferential statistics were completed to include a 
one pair tailed t- test comparing pre-and post-test case study scores for healthcare provider group 
and the non-healthcare provider group.  
Outcomes/Project Results 
Descriptive statistics were used to describe the sample and outcome variables. The age of 
the subjects ranged from 25 to 74 years. The sample (n= 18) consisted of 12 (67%) females and 6 
(33%) males. The majority (89%) of the sample had an educational degree of a Master’s degree 
or higher. The sample size was made up of 12 healthcare providers and 6 individuals that were 
not providers. The healthcare provider sample (n= 12) was made up of 2 (11%) nurse 
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practitioners, 6 (33%) physician assistants and 4 (22%) physicians. There was no statistical 
significance in the descriptive statistics except for a significant increase in healthcare provider 
pre-test to post-test case study scores. A one tail paired t-test was performed to compare the pre-
and post-test case study scores. The mean of the pre-test case study scores was 3.57 (SD= 1.60), 
and the mean of the post-test case study scores was 6.21 (SD= 1.97). A significant increase from 
pre-test to post-test case study scores was found (t(13)= -6.19, p < 0.00). Of the healthcare 
providers, over half (57%) found the tool “moderately helpful” and 61% of them plan to 
incorporate the tool in practice at least “some of the time.” The non-provider sample (n=6) was 
made up of 1 Licensed Practical Nurse, 1 Clinical Nurse Specialist and 4 unknown. The non-
provider sample was too small to run any inferential statistics. Of the non-providers, half (50%) 
found the tool “extremely helpful” and plan to use the tool “all of the time.” The data suggests a 
statistical significance in improvements in post test case study scores for healthcare providers, 
showing an increase in knowledge from pre-intervention to post intervention. The data also 
suggests that the majority of healthcare providers and nurses planned to use the tool in practice, 
75% of the non-providers and 85% of the healthcare providers reported that they plan to use this 
tool in practice. 
Discussion 
 Through this study it was determined that by educating and implementing a severity 
stratification tool, staff knowledge improves and staff have a plan for an increased use of the tool 
in practice. At the provider and nurse level the impact of the project was seen through the data 
that reflects improvements of case study scores and willingness to use the tool in practice. This 
translated to the participants actually planning to implement the CREST tool into their own 
practice. At a system level, after completion of the project, administration is considering making 
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the CREST tool educational PowerPoint and algorithm accessible and mandatory to all 
providers. Since changing policy in this public-sector organization is difficult, no plans are in 
place at this time to make the CREST tool algorithm and its use a part of policy, but may at least 
be making the education portion mandatory. Having the education portion mandatory for 
providers could be a stepping stone to making the algorithm available as a procedural tool as 
well. The project intervention is planned to be sustained by a second-year Doctor of Nursing 
Practice student. This student plans to continue the project with her focus on implementing the 
CREST tool and algorithm facility wide. Through implementing this tool facility wide in 
practice, she plans to look at specific patient outcomes and financial spending. This is expected 
to be implemented by next fall. The financial implications of this study were very minimal. The 
only cost was minimal and was covered by the project leader as costs for snacks at the 
educational session. As for longevity of this project the only cost would be paying employees to 
undergo the training session, which could easily be completed in 30 minutes to an hour. 
Implementing education on a severity stratification tool is a low cost and efficient intervention to 
improve staff knowledge of SSTI’s.  
This study had several limitations. By sharing in these experiences hopefully these 
limitations will be avoided as the project is sustained and carried forward. One of the limitations 
of this study is the small sample size (n= 18) and non-provider sample size (6). Only inferential 
statistics could be conducted on the provider sample, not on the non-provider sample group, 
since the non-provider sample was too small to run any inferential statistics. With a larger 
sample size, inferential statistics in the non-provider group could be included. This leaves much 
room for additional studies with larger sample sizes to further explore the use of the tool and 
knowledge of the tool in practice. Another limitation to the study was that the participants were 
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asked their job title as a multiple-choice question. Several participants left this section blank.  It 
was discovered later that several x-ray technicians and physical therapists attended the provider 
meeting. This finding could have potentially skewed the data results. The strengths of the study 
were the larger sample size of the healthcare providers, which allowed for inferential statistics to 
be completed, determining that the health care provider group had a statistically significant 
increase in knowledge from pre-intervention to post intervention. Another strength of the study 
was the attrition rate, no participants exited the study early and all participants who completed a 
pretest also completed a post test, improving the consistency of the data that was obtained.  
Conclusion 
 Through this evidence based project it was determined that by implementing an 
educational session on a severity stratification tool for SSTI’s, healthcare providers had an 
improvement in knowledge related to diagnosing and treating SSTI’s using the CREST tool. Not 
only was staff knowledge improved, but the majority of participants found this tool to be helpful 
and had plans to incorporate it into their daily practice. Hopefully now this project can be moved 
one step further to determine if it is actually being used by healthcare staff in the field. By 
arming healthcare staff with the knowledge of the CREST tool, there is an opportunity to 
diagnoses and treat SSTI’s early on to promote improved communication amongst health care 
staff, improved assessment coordination and ultimately improved patient outcomes for this high 
risk and vulnerable population.      
SKIN AND SOFT TISSUE INFECTIONS  
 
  
21 
References 
Figtree, M., Konecny, P., Jennings, Z., Goh, C., Krilis, S. A., & Miyakis, S. (2012). Risk 
stratification and outcome of cellulitis admitted to hospital. Journal of Infection, 60(6), 
431-439. 
Flanagan, M. (2014). Barriers to the implementation of best practice in wound care. Wounds,  
15(1), 74-82.  
Hashem, N. G., Hidayat, L., Berkowitz, L., & Venugopalan, V. (2016). Management of skin and  
soft-tissue infections at a community teaching hospital using a severity-of-illness tool. 
Journal of Antimicrobial Chemotherapy, 71(11), 3268-3275.  
Jenkins, T. C., Knepper, B. C., Sabel, A. L., Sarcone, E. E., Long, J. A., Haukoos, J. S., ... &  
Mehler, P. S. (2011). Decreased antibiotic utilization after implementation of a guideline 
for inpatient cellulitis and cutaneous abscess. Archives of internal medicine, 171(12), 
1072-1079. 
Lane, S., Johnston, K., Sulham, K. A., Syed, I., Pollack, C. V., Holland, T., & Nathwani, D.  
(2016). Identification of patient characteristics influencing setting of care decisions for 
patients with acute bacterial skin and skin structure infections: results of a discrete choice 
experiment. Clinical therapeutics, 38(3), 531-544. 
Lee, B. Y., Singh, A., David, M. Z., Bartsch, S. M., Slayton, R. B., Huang, S. S.,…Daum, R. R.  
(2013). The economic burden of community‐ associated methicillin‐ resistant 
Staphylococcus aureus (CA‐ MRSA). Clinical Microbiology and Infection, 19(6), 528-
536. 
Lee, G.C., Hall, R. G., Boyd, N. K., Dallas, S. D., Du, L. S., Trevino, L. B.,…Trevino, S. B.  
(2016). A prospective observational cohort study in primary care practices to identify  
SKIN AND SOFT TISSUE INFECTIONS  
 
  
22 
factors associated with treatment failure in Staphylococcus aureus skin and soft tissue 
infections. Annals of Clinical Microbiology and antimicrobial, 15(58), 1-7.  
Malcolm, B. (2011). The Rise of Methicillin-Resistant Staphylococcus aureus in U.S.  
Correctional Populations. Journal of Correctional Health Care: The Official Journal of 
the National Commission on Correctional Health Care, 17(3), 254–265. 
doi.org/10.1177/1078345811401363 
Marwick, C., Broomhall, J., McCowan, C., Phillips, G., Gonzalez-McQuire, S., Akhras, K., ... &  
Davey, P. (2011). Severity assessment of skin and soft tissue infections: cohort study of 
management and outcomes for hospitalized patients. Journal of Antimicrobial 
Chemotherapy, 66(2), 387-397. 
Marwick, C., Rae, N., Irvine, N., Davey, P., Marwick, C., Rae, N., ... Davey, P. (2011).  
Prospective study of severity assessment and management of acute medical admissions 
with skin and soft tissue infection. Journal of Antimicrobial Chemotherapy (JAC), 67(4), 
1016-1019. doi:10.1093/jac/dkr554 
Miller, L.G., Eisenberg, D.F., Liu, H., Chang, C., Wang, Y., Luthra, R., … Suaya, J.A. (2015).  
Incidence of skin and soft tissue infections in ambulatory and inpatient settings 2005-
2010. Bio Med Central Infectious Disease, 15, 362.  
Mullen, L. A. & O’Keefe, C. (2015). Management of skin and soft tissue infections in a county  
Correctional facility: A quality improvement project. Journal of Correctional Health 
Care, 21(4), 335-364.  
Nilsen, P. (2015). Making sense of implementation theories, models and  
frameworks. Implementation Science, 10(1), 53. 
Ramakrishan, K., Salinas, R.C. & Higuita, N.I. (2015). Skin and soft tissue infections. American  
SKIN AND SOFT TISSUE INFECTIONS  
 
  
23 
Family Physician, 92(6), 474-483.  
Ray, G.T., Suaya, J.T. & Baxter, R. (2013). Incidence, microbiology, and patient characteristics  
of skin and soft-tissue infections in a US population: a retrospective population-based 
study. BMC infectious diseases, 13(1), 252. 
Schaffer, M. A., Sandau, K. E., & Diedrick, L. (2012). Evidence‐based practice models for  
organizational change: overview and practical applications. Journal of advanced 
nursing, 69(5), 1197-1209. 
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, J. C., Gorbach, S. L.,  
… Wade, J.C. (2014). Practice guidelines for the diagnosis and management of skin  
and soft tissue infections: 2014 update by the Infectious Diseases Society of America. 
Clinical Infectious Diseases, 59, e10-e52.  
Suaya, J.A., Mera, R.M., Cassidy, A., O’Hara, P., Amrine-Madsen, H., Burstin, S. & Miller,  
L.G. (2014). Incidence and cost of hospitalizations associated with staphylococcus aureus 
skin and soft tissue infections in the United States from 2001 through 2009. Bio Med 
Central Infectious Disease, 14, 296.  
Talan, D. A., Salhi, B. A., Moran, G. J., Mower, W. R., Hsieh, Y., Krishnadasan, A. & Rothman,  
R. E. (2014). Factors associated with decision to hospitalize emergency department  
patients with skin and soft tissue infections. Western Journal of Emergency Medicine, 1, 
89-97.  
Tiwari, A.K. & Lal, R. (2014). Study to evaluate the role of severity stratification of skin and  
soft tissue infections in formulating treatment strategies and predicting poor prognostic 
factors. International Journal of Surgery, 12, 125-133.  
Wilson, S. E., Solomkin, J. S., Le, V., Cammarata, S. K., & Bruss, J. B. (2011). A severity score  
SKIN AND SOFT TISSUE INFECTIONS  
 
  
24 
for complicated skin and soft tissue infections derived from phase III studies of 
linezolid. The American journal of surgery, 185(4), 369-375. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SKIN AND SOFT TISSUE INFECTIONS  
 
  
25 
Appendix A 
Search Strategy 1 
PubMed 
 
 
       
 
 
Appendix B 
SKIN AND SOFT TISSUE INFECTIONS  
 
  
26 
Search Strategy 2 
EBSO host 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C 
SKIN AND SOFT TISSUE INFECTIONS  
 
  
27 
Search Strategy 3 
Web of Science 
 
 
 
 
 
 
 
 
 
 
 
SKIN AND SOFT TISSUE INFECTIONS IN HIGH RISK POPULATIONS 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,  
 
28 
Appendix D 
Evaluation Table 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
Measureme
nt/ 
Instrument
ation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Figtree, M. 
(2012). Risk 
stratification 
and outcome of 
cellulitis 
admitted to 
hospital.  
 
Funding:  
None 
 
Conflict/Bias: 
None 
 
 
Country: 
Sydney 
Millio’s 
framework 
for 
prevention  
Design: 
Retrospective 
cohort study  
 
Purpose: To 
identify risk 
factors associated 
with mortality and 
adverse outcomes 
of community 
acquired cellulitis 
requiring hospital 
admission  
N= 395 
 
n= 1 
 
SS= 1 650 bed 
Tertiary referral 
hospital in 
Sydney, Australia  
 
M age= 70.6 
 
F= 57% 
  
IC= 
Hospitalization 
between January 
1999 and 
December 2006, 
diagnosis code for 
cellulitis 
 
IV1- Age>60  
 
IV2- Impaired 
mobility  
 
IV3- > Co-
morbidities 
 
IV4- Albumin <30 
 
IV5= symptoms > 4 
days 
 
IV6= Antibiotics 
delayed >8 hours 
 
 
DV1=Hospital stay 
>7days 
Predictive 
risk tool 
model 
created by 
authors 
Pearson’s 
chi square, 
Fischer’s 
exact test, 
One way 
analysis of 
variance, 
univariate 
analysis, 
logistic 
regression, 2 
tailed tests 
of 
significance  
P= <0.05 
IV1-  
P= <0.001* 
 
Iv2- 
P= <0.001* 
 
IV3= 
P= 0.004* 
 
IV4=  
P=<0.001* 
 
IV5=  
P<0.001* 
 
IV6=  
P< 0.001* 
 
DV1=36.1% 
 
Findings: Pt 
LOE: Level III 
 
W: Study design, 
selection bias, 
associations 
detected are not 
necessarily 
causations but 
associations, 
residual 
confounding 
may have 
occurred, study 
pertains to 
cellulitis SSTI’s 
only.  
 
S: Stringent 
inclusion and 
exclusion 
criteria, practical 
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age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
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EC= Myositis, 
necrotizing 
fasciitis, diabetic 
foot infections, 
<16 years of age 
 
with admission 
risk factor <4 at 
a low risk of 
adverse 
outcomes, Risk 
increased with 
score. 
Multivariate 
factors 
independently 
associated with 
hospital stay > 
7days included 
age >60, 
symptom 
duration> 
4days, 
Bacteremia.  
clinical 
endpoints, 
largest study of 
in-hospital 
mortality 
 
APP: 
Appropriate risk 
stratification can 
prioritize 
patients for 
timely antibiotic 
administration. 
This study can 
help provider to 
know using risk 
stratification 
whether patient 
needs to be 
admitted or can 
remain in 
community.  
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
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nt/ 
Instrument
ation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
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A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
30 
Hashem, N.G. 
(2016). 
Management of 
skin and soft 
tissue infections 
at a community 
teaching 
hospital using a 
severity of 
illness tool.  
 
Funding: None 
 
Conflict/Bias: 
None 
 
Country: USA 
Levels of 
prevention 
model 
Design: 
Retrospective 
Cohort study  
 
Purpose: To 
retrospectively 
apply CREST to a 
Cohort of 
hospitalized 
patients with 
SSTI’s and to 
assess the 
relationship 
between disease 
severity and 
appropriateness of 
antimicrobial 
management.  
N= 200 
 
n= 1 
 
SS= one 416 bed 
community 
teaching hospital 
in Brooklyn, NY 
 
M age= 54  
 
M= 53% 
IC= Primary 
discharge 
diagnosis SSTI, 
admitted from 
January to 
December 2011, 
>18 years of age,  
 
EC= Admitted 
with cellulitis 
associated with 
DM, <18 years of 
age.  
 
 
IV1- Severity of 
SSTI 
 
IV2- Early 
recognition of SSTI 
 
DV1- Over-treatment   
 
DV2-Under-
treatment  
 
DV3- Complete Final 
response   
 
DV4- Clinical 
Stability  
IV1- 
CREST 
scoring  
 
IV2- 
SEWS 
Scoring 
(Class I 
least 
severe- 
class 4 
most 
severe)  
 
DV1, 
DV2,- 
Measured 
based on 
antimicrobi
al route and 
spectrum of 
activity 
based on 
suspected 
pathogens 
in each 
severity 
class.  
 
DV3, DV4- 
ANOVA, 
Fischer’s 
Exact test 
 
P<0.05 
IV1- 
Statistically 
significant  
 
IV2- 
Statistically 
significant  
 
DV1- 
Overtreatment 
most common 
in least severe 
classes 
P= <0.05* 
 
DV2- 50% class 
4 undertreated 
 
 
DV3- 83% of 
classes 1 
through 3 
achieved 
complete 
response. 
 
DV4- Median 
time 3 days in 
classes 1 - 3 
 
LOE: Level III 
 
W: study design, 
patient 
classifications 
were not 
assessed by an 
independent 
viewer; CREST 
is not applicable 
to MRSA 
patients.  
 
S: Easy 
application of 
CREST tool to 
clinical practice, 
can use in 
hospital setting 
or outpatient 
setting, low cost  
 
APP: By using 
severity scoring 
for SSTI’s 
providers can 
ensure adequate 
treatment for 
SSTI.  
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A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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measured 
as number 
of days 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
Measureme
nt/ 
Instrument
ation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Jenkins, T.C. 
(2011). 
Decreased 
antibiotic 
utilization after 
implementation 
of a guideline 
for inpatient 
cellulitis and 
cutaneous 
abscess.  
 
Funding: 
Department of 
patient safety 
and quality, 
Denver Health 
Millio’s 
framework 
for 
prevention, 
Levels of 
prevention 
model 
Design: 
Retrospective Pre-
intervention and 
post-intervention 
study 
 
 
Purpose: To 
explore whether 
implementing an 
institutional 
guideline to 
standardize and 
streamline the 
evaluation and 
treatment of 
inpatient cellulitis 
N= 344 
 
n= 
CO n= 169 
I n= 175 
 
Median age: 
CO=46 
I=47 
 
M: 
CO= 75% 
I= 66% 
 
SS= Denver 
health integrated 
system (includes 
IV= Without 
standardized 
treatment plan   
 
IV2=With 
standardized 
treatment plan  
 
DV1= Duration of 
therapy 
 
DV2= Days 
antibiotic therapy 
administered 
 
DV3= Clinical failure 
(Treatment failure, 
SAS Data 
analysis 
 
DV1= 
Number of 
calendar 
days Pt 
received 
treatment 
 
DV2= Sum 
of calendar 
days of 
each 
antibiotic 
administere
d 
Pearson X, 
Fischer 
exact, 
Wilcoxon 
rank sum 
 
P<0.5 
IV= 
Statistically 
significant 
 
IV2=Statisticall
y Significant 
 
DV1= 
Decreased by 3 
days in I group 
P<0.001* 
 
DV2=  
P=Decreased in 
I group 
P<0.001* 
 
LOE: Level III 
 
W: Reviewer 
bias due to study 
design, Subject 
to period effect, 
study preformed 
at a single 
institution, 
preformed on 
only a subset of 
patients with 
SSTI’s 
 
S: Intervention is 
broadly 
applicable, uses 
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A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
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medical center 
 
Conflict/Bias: 
None 
 
Country: USA 
and abscess would 
decrease antibiotic 
and health care 
resource 
utilization.  
 
hospital, ED, 
urgent care, sub-
specialties, 
primary care, 
public health)  
 
IC= Principal 
discharge 
diagnosis of 
cellulitis or 
cutaneous abscess 
from January 1st 
2007 to December 
31st 2007 or July 
9th 2009 to July 8th 
2010, >19 years 
of age 
 
EC= <19 years of 
age, transferred 
from another 
hospital, leaving 
against medical 
advice, chronic 
ulcer, peripheral 
arterial disease, 
animal/human 
bite, necrotizing 
fasciitis, or 
hospital 
recurrence of re-
hospitalization)  
 
DV4= Use of serum 
ESR, CRP 
 
DV5= 
Microbiological 
cultures 
 
DV6= Imaging 
 
DV7= Length of 
hospital stay 
 
DV3=  
Number of 
patients 
with 
treatment 
failure, 
reoccurrenc
e re-
hospitalizat
ion in a 30 
day period  
 
DV4= 
Number of 
ESR, CRP 
use 
 
DV5= 
Number 
patient 
cases that 
used 
cultures 
 
DV6= 
number of 
cases 
imaging 
was used 
DV3=   
CO- 7.7% 
I- 7.4% 
P=0.93 
 
 
DV4= 
P= 0.006* 
 
DV5=  
Decreased with 
I group 
P=0.003* 
 
DV6= 
Decreased with 
I group  
P= 0.2* 
 
DV7=   
P=0.43 
only a minimal 
amount of 
financial 
resources 
 
APP: 
Implementation 
of a clinical 
practice 
guideline for 
cellulitis and 
cutaneous 
abscesses results 
in shorter 
durations of 
more targeted 
antibiotic 
therapy, with a 
decrease in use 
of healthcare 
resources 
without 
negatively 
effecting pt. 
outcomes.  
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Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
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necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
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admission, 
Nursing home or 
surgery within last 
90 days. Stay in 
ICU 
 
 
 
DV7= Sum 
of calendar 
days of 
hospital 
stay 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
Measureme
nt/ 
Instrument
ation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Lane, S. (2016). 
Identification of 
patient 
characteristics 
influencing 
setting of care 
decisions for 
patients with 
acute bacterial 
skin and skin 
structure 
infections: 
Results of a 
discrete choice 
experiment. 
 
Funding: The 
Multifactorial 
Causation 
Theory  
Design: 
Observational 
Cross-sectional 
study 
 
Purpose: To 
understand the 
patient attributes 
that affect clinical 
decision-making 
regarding the 
setting of care for 
ABSSSI 
treatment.  
 
Method: 3 part 
Online Survey  
N= 400 
 
M age=  
USA- 45 
UK- 42 
 
M= 
USA- 64.5% 
UK- 70% 
 
SS=USA, United 
Kingdom 
providers (50 
emergency room 
specialists, 50 
infectious disease 
specialists, 50 
IV1- Severity of 
ABSSSI 
 
IV2- Comorbidities 
 
IV3- Age 
 
IV4- Lack of 
adherence 
 
DV1= Decision to 
treat as inpatient or 
outpatient  
 
 
IV1- Mild, 
moderate, 
severe 
depending 
on presence 
of fever, 
abnormal 
VS, SIRS 
criteria, 
Sepsis or 
organ 
failure  
 
IV2-
classified 
as minor or 
major  
Multinomial 
Model  
 
CI: 95% 
 
Mixed 
effects 
Model  
IV1- Severe 
ABSSSI 
resulted in 
decreased 
percentage of 
outpatient 
treatment CI 
0.02 – 0.07 
 
Mild ABSSSI 
resulted in 
increased 
probability of 
outpatient 
treatment CI 
0.94 to 0.99 
 
LOE: Level II 
 
W: Convenience 
sample and may 
not represent 
general 
population, 
nature of sample 
could have 
introduced 
selection bias, 
differing 
definitions of 
mild, moderate 
and severe 
ABSSSI’s exists 
which could 
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A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
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age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
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Medicines 
Company  
 
Conflicts/Bias: 
The author is an 
employee of the 
Medicines 
Company, 
which is 
company in the 
biopharmaceuti
cal industry 
 
Country:  
United 
Kingdom 
 
 hospitalists, 50 
nurse 
practitioners) 
 
IC= Medical 
Providers 
experienced with 
treating 
ABSSSI’s, >18 
years of age, must 
live in USA or 
United Kingdom 
 
EC= other 
professions beside 
medical provider, 
Lives outside of 
USA or United 
Kingdom 
 
IV4- 
Identified 
an non-
adherent if 
antimicrobi
al doses 
missed or 
missed 
appointmen
t 
IV2- Severe co-
morbidities 
outpatient 
treatment 
probability 
<50% 
 
IV3- <75 years 
of age 
probability 
range of 
treating as 
outpatient 
decreased to 
0.28 – 0.61.  
 
IV4- Not 
significant 
 
 
Findings: 
Severe 
comorbidities 
and age >75 
years of age 
were important 
indicators of 
inpatient 
treatment  
affect 
interpretation of 
results 
 
S: Eliciting 
treatment 
preferences from 
a variety of 
medical 
providers, 
providers 
recruited from a 
variety of 
practice types, 
large SS, 
experimental 
design 
demonstrated 
orthogonality 
and level 
balance.  
 
APP: Identifying 
key factors that 
affect ABSSSI’s 
treatment plan. 
Highlights 
importance of 
severity 
stratification in 
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facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
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determining 
treatment of 
ABSSSI’s.  
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
Measureme
nt/ 
Instrument
ation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Lee, G.C. 
(2016). A 
prospective 
observational 
cohort study in 
primary care 
practices to 
identify  
factors 
associated with 
treatment failure 
in 
Staphylococcus 
aureus skin and 
soft tissue 
infections. 
 
Funding: Pfizer 
Normalizatio
n Process 
Theory, 
which is the 
theory of 
looking at 
complex 
interventions 
that have 
been put into 
place and 
evaluating 
them. This 
correlates 
with the 
treatment 
failure rate 
and risk 
Design= 
PCS 
 
Purpose=To 
identify risk 
factors 
contributing to 
treatment failure 
associated with 
CA-MRSA 
SSTI’s.  
N= 106 patients 
M age= 41 
M= 50% 
H= 74% 
O= 54% 
 
n= 84 (no 
treatment failure) 
M age= 40 
M= 52% 
H=76% 
0= 50% 
 
n= 22 (treatment 
failure) 
M age= 45 
M= 41% 
H= 64% 
IV1- MRSA 
phenotype 
 
IV2-MSSA 
phenotype 
 
IV3- Largest size 
diameter of the 
wound  
 
IV4- Duration of skin 
infection  
 
DV1- Treatment 
failure  
IV1, IV2- + 
or negative 
blood 
cultures 
 
IV3- >5cm 
wound 
measureme
nt 
 
IV4- 
number of 
days >7 
days 
 
DV1- 
Measured 
by ER or 
Bivariate 
Analysis  
 
P=< 0.05 
 
Breslow 
Day test 
95% CI 
IV1- No 
statistical 
significance 
 
IV2- No 
statistical 
significance 
 
IV3- CI: 1.58- 
17.20. ES: 3.53 
 
IV4- CI: 1.74- 
19.61. ES: 4.80 
 
DV1- 
P= 0.32 
 
Findings: 
LOE: Level II 
 
W: Limited SS, 
social/behavioral 
risk factors not 
included, 
compliance of 
antimicrobials 
was no assessed 
 
S: First study to 
look at wound 
size as risk 
predictor, no 
bias, focused on 
primary care 
setting 
 
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
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Conflicts/Bias: 
Pfizer could 
present bias on 
antibiotic 
treatment plans 
selected in this 
study since it is 
a 
pharmaceutical 
company.  
 
Country: USA 
 
 
factors for 
this rate.  
O=  71% 
 
SS= 14 primary 
care clinics in 
South Texas  
 
IC= Provided 
informed consent, 
at least 18 years 
of age or older 
and presented to 
one of the 
included clinics 
with a SSTI.  
 
EC= <18 years of 
age, no informed 
consent and no 
SSTI diagnosis.  
 
Treatment Failure 
definition: need 
for new antibiotic 
course/therapy, 
I&D, ER or 
hospital visit in 
post 90 days 
hospital 
visit in post 
90 days 
MRSA 
infections do 
not have worse 
outcomes than 
MSSA 
infections. 
MRSA is not a 
reliable 
indicator of 
SSTI severity. 
Duration of 
infection and 
wound diameter 
were strongest 
risk predictors 
for treatment 
failure.  
 
 
APP: Identify 
predictors for 
treatment failure 
can help target 
risk factors for 
severity of 
SSTI’s. This 
study further 
strengthens the 
argument of time 
to effective 
treatment is a 
major factor in 
poor clinical 
outcomes and 
treatment failure  
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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Marwick, C. 
(2011).  
Prospective 
study of 
severity 
assessment and 
management of 
acute medical 
admissions with 
skin and soft 
tissue infection. 
 
Funding: None 
 
Conflict/Bias: 
None 
 
Country: 
Scotland 
Levels of 
prevention 
model  
Design: 
Retrospective 
cohort study 
 
Purpose: To 
identify patients 
with SSTI’s to 
explore clinical 
management, 
illness severity 
and outcomes 
 
 
N= 79 
N1= 37 
N2= 4 
N3= 27 
N4= 11 
 
n= 1 
 
SS= 2 hospitals in 
Scotland 
M=65% 
SI= 70% arm 
AGR= 37-69 
 
IC= Patient’s had 
to be seen for 
treatment between 
April 2009 and 
June 2010, >18 
years of age, 
primary diagnosis 
of SSTI who 
received 
antimicrobials  
IV1= Patients with 
blood cultures 
 
IV2= Patients 
without blood 
cultures 
 
IV3= Diabetes 
Mellitus 
 
IV4= Appropriate 
Treatment  
 
IV5= Inappropriate 
Treatment  
 
IV6= Age 
 
IV7= Charlson Index  
 
IV8= Severity Index 
 
IV9= SEWS 
 
CREST 
Severity 
Scale 
 
Ki/Rostein 
Severity 
Classificat
ions 
 
SEWS 
Classificat
ion  
ANOVA 
 
Two-Way 
KAPPA 
test 
 
P<0.5 
CI= 95% 
IV1- no 
statistical 
significance 
 
IV2- no 
statistical 
significance 
 
IV3-  
CI: 0.98 – 
1.31. OR: 1.13 
 
IV4- 
CI: 0.41- 0.80 
P<0.01. 
OR: 1.0 
 
IV5-  
CI: 1.07- 
30.09 
OR: 0.57 
 
LOE: Level III 
 
W: Outside of 
US, 2 sites, 
Small SS, data 
1 year, Level 
III 
 
S: significant 
results  
 
FE: Safe, easy 
to use index 
scales 
 
APP: 
Appropriate 
treatment, age, 
severity index, 
SEWS scale, 
SIRS scale 
affect 
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A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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EC= Patients seen 
out of date range, 
< 18 years of age, 
lacking a primary 
diagnosis of SSTI 
 
 
 
 
 
IV10= SIRS 
 
DV1= Mortality  
 
IV6- 
P<0.07 
 
IV7-  
P<0.27 
 
IV8- 
P<0.004 
 
IV9- 
P<0.002 
 
IV10- 
P<0.266 
 
DV1- 
Statistically 
significant 
mortality. 
Implementation 
of these 
index/scales 
could decrease 
incidence of 
mortality in 
SSTI’s.  
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
Measureme
nt/ 
Instrument
ation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Marwick. C. 
(2011). 
Prospective 
study of 
Levels of 
Prevention 
Model  
Design: 
Prospective Study 
 
Purpose: To 
N= 79 
 
n= 2  
 
IV1=Timeframe 
antibiotics given  
 
IV2= Comorbidities 
IV1- 
hours  
 
IV2, IV3, 
Fisher’s 
Exact Test 
 
Kappa 
IV1- P<0.05 
 
IV2- Not 
significant 
LOE: Level II 
 
W: Small study 
population, 
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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severity 
assessment and 
management of 
acute medical 
admissions with 
skin and soft 
tissue skin 
infections.  
 
Funding: None 
 
Conflict/Bias: 
None 
 
Country: 
Scotland 
prospectively 
identify patients 
with SSTI’s 
presenting from 
the community, to 
document clinical 
management, 
illness severity 
and outcome 
M age= 52 
 
M= 65% 
 
SS= Acute 
Medical 
Admissions for 2 
hospitals in 
Scotland 
 
IC=>18 years of 
age, primary 
diagnosis of SSTI 
who received 
antibiotics, 
admission 
between April 
2009 and June 
2010 
 
EC= <18 years of 
age, no primary 
diagnosis of SSTI, 
admission outside 
of April 2009 and 
June 2010 
 
IV3= Physiological 
Parameters 
 
IV4= Site of SSTI 
 
IV5= Size of SSTI 
 
IV6= Presence of 
absence of 
necrotizing fasciitis 
 
IV7= Severity of 
SSTI 
 
DV1= Adverse 
Patient outcomes  
 
DV2=Appropriatenes
s of antibiotics 
IV4, IV5, 
IV6-
CREST 
severity 
classificati
on, 
Ki/Rotstei
n criteria, 
Tayside 
Formulary 
 
DV1: 
measured 
as death 
within 30 
days or re-
admission 
to hospital 
within 30 
days 
 
 
Statistic  
 
CI= 95% 
 
IV3- Not 
significant 
 
IV4- Not 
significant 
 
IV5- Not 
significant 
 
IV6- not 
significant 
 
IV7-not 
significant 
 
DV1= 6% 
 
DV2= P<0.01 
small number 
of adverse 
outcome events 
 
S: Prospective 
design, 
ensuring the 
appropriate 
diagnosis for 
enrollment and 
ensuring no 
sampling bias 
 
FE: May not be 
feasible to 
apply to 
primary care 
setting 
 
APP:  Over 
treatment of 
mild infections 
and under-
treatment of 
severe SSTI’s 
is a common 
practice that is 
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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identified in the 
data. High 
incidence of 
wasteful 
investigation, 
time and 
resources to 
include blood 
cultures.  
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
Measureme
nt/ 
Instrument
ation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Talan, D. A. 
(2014). Factors 
associated with 
decision to 
hospitalize 
emergency 
department  
patients with 
skin and soft 
tissue 
infections. 
 
Funding: 
Center’s for 
Multifactorial 
Causation 
Theory 
Design: 
Prospective 
Cohort study  
 
Purpose: To 
identify factors 
that influences the 
physicians’ 
decision to 
hospitalize a 
patient with a 
SSTI.  
 
N= 619 
 
n=1 
 
SS= 12 USA 
ED’s 
 
M age= 38.7 
 
M= 57.5% 
 
AA= 51.5% 
 
CM= 32.5% 
IV1= History of 
failed treatment 
 
IV2= A 
 
IV3= Comorbidity  
(Prior MRSA 
infection, Diabetes, 
chronic ulcer, edema, 
bed ridden)  
 
IV4=Infection type 
(abscess, cellulitis, 
infected wound)  
Survey for 
physicians 
on reasons 
for 
admission 
and clinical 
characterist
ics 
Statpages 2 
way 
contingenc
y table 
analysis  
 
CI: 95% 
 
Chi-Square 
Binary 
recursive 
partitioning 
IV1= 
CI- 
1.38 -3.72* 
ES: 1.76 
 
IV2= 
CI-1.11-5.08* 
ES: 2.86 
 
IV3= CI- 2.25-
5.00* 
ES: 3.35 
 
IV4=  
LOE: Level II 
 
W: SS ED only, 
instrumentation 
used physician 
survey, did not 
take into account 
admission 
related to 
inability to 
preform wound 
care due to adl 
restrictions 
 
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
41 
Disease Control 
 
Conflicts/Bias: 
None 
 
Country: USA 
 
SSTI type: 85.1% 
abscess  
 
IC= >18 years of 
age, SSTI with 
symptoms <1 
week, purulent 
exudate available 
for culture, ED 
patients only.  
 
EC=  < 18 years 
of age, SSTI 
symptoms >1 
week,  
 
 
 
 
 
IV5 =Infection 
mechanism (chronic 
wound, infection of 
surgical wound) 
 
IV6= Infection 
location (groin, lower 
extremity) 
 
IV7=Symptoms 
(fever, chills, 
nausea/vomiting, 
extreme 
pain/tenderness, local 
edema) 
 
IV8=Size of wound 
 
IV9=Abnormal 
Imaging results 
 
IV10=Vital signs 
abnormalities (fever, 
tachypnea, 
tachycardia) 
 
 
 
DV1= Admitted with 
CI-  
2.31- 5.22* 
ES: 3.47 
 
IV5=  
CI-  
2.06 -6.77* 
ES: 6.77 
 
IV6=  
CI- 
1.13-2.49* 
ES: 1.69 
 
IV7= 
CI- 
2.92- 5.96* 
ES: 4.21 
 
IV8= CI- 
2.57 -6.62* 
ES: 4.09 
 
IV9= 
CI- 1.42- 3.84* 
ES: 1.74 
 
IV10= 
CI- 
2.60-5.66* 
S: Adequate 
sample size, 
variety of 
significant 
variables 
 
FE: Safe, low 
cost 
 
APP: Reasons 
physicians 
choose to admit 
a patient to the 
hospital for SSTI 
pertain to clinical 
characteristics of 
wound and 
patient history. A 
better 
understanding of 
reasoning behind 
physicians to 
hospitalize can 
help to 
streamline this 
process and 
admit 
unnecessary 
admissions from 
occurring.  
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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SSTI 
 
DV2= Discharged 
with SSTI 
ES: 4.02 
 
DV1= 
Statistically 
significant 
 
DV2= 
Statistically 
significant  
 
 
 
 
 
 
 
 
 
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
Measureme
nt/ 
Instrument
ation 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Tiwari, A.K. 
(2014). Study to 
evaluate the role 
of severity 
stratification of 
skin and  
Incidence, 
prevalence, 
mortality 
model 
 
Multifactorial 
Design: 
Prospective 
cohort study  
 
Purpose: To 
explore the 
N= 105 
n 1=35 
n 2= 70  
 
SS= 1 hospital in 
New Delhi’s 
IV1= fever  
 
IV2= History of 
wound (trauma, 
animal or insect 
bite) 
Department’s 
Protocol 
Severity 
Stratification 
classification  
Chi-Square 
Binary 
recursive 
partitioning 
 
P<0.05 
IV1=  <0.0001* 
 
IV2= 0.069* 
 
IV3= <0.0004* 
 
LOE: Level II 
 
W: Small sample 
size, setting 
surgical 
outpatient, 
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
43 
soft tissue 
infections in 
formulating 
treatment 
strategies and 
predicting poor 
prognostic 
factors. 
 
Funding: None 
 
Conflicts/Bias: 
None 
 
Country: New 
Delhi 
causation 
theory  
clinical profile of 
CA SSTI’s, to 
evaluate the 
existing method 
of severity 
stratification and 
to identify factors 
for poor outcomes 
and lengthened 
hospitalizations.  
 
 
surgical outpatient 
department and 
ED 
AGR= 15-71 
M age= 41.2 
M= 83.81 % 
 
IC= Presence of at 
least 2 of the 
following: 
swelling, 
erythema, severe 
pain, induration, 
abscess or 
tenderness to 
palpation. 
Presence of 1 of 
the following: 
body temperature 
> 40 Celsius <35 
Celsius, WBC 
counts >15,000 or 
wound culture. 
Diagnosis of 
severe infection 
such NF 
EC= Patient with 
trivial injury, 
patient with 
hospital acquired 
 
IV3= Gangrene 
 
IV4= BSA 
 
IV5= Loss of 
sensation 
 
DV1= Healthy 
wound 
 
DV2= Negative 
culture wound  
 
DV3= Unhealthy 
wound  
 
DV4= Positive 
wound culture  
IV4= <0.001* 
 
IV5= <0.0365* 
 
  
 
outside of USA 
population 
 
S: No Bias, Well 
described 
intervention, 
appropriate 
statistical 
analysis 
 
FE: Safe, Low 
cost 
 
APP: The 
existing severity 
stratification 
model does 
decrease healing 
time of SSTI’s, 
but it could use 
some 
modifications 
that the Severity 
stratification 
model identified 
in this study. 
Based on the 
conclusions of 
the study, 
researchers 
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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infection, <12 
years of age, 
infection other 
than skin or soft 
tissue. 
created an 
accurate 
algorithm for 
early detection, 
diagnosis and 
treatment.  
Citation Theory/ 
Conceptual 
Framework 
Design/ Method Sample/ Setting Major Variables & 
Definitions 
Measurement
/ 
Instrumentati
on 
Data 
Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality of 
Evidence; 
Decision for 
practice/ 
application to 
practice 
Wilson, S.M. 
(2011). A 
severity score 
for complicated 
skin and soft 
tissue infections 
derived from 
phase III studies 
of Linezolid.  
 
Funding: 
Pharmacia and 
Upjohn  
 
Conflict/Bias:  
Study is funded 
by 
pharmaceutical 
Incidence, 
prevalence, 
mortality 
model 
 
Design: 
Prospective 
comparative 
Randomized trial 
 
Purpose: To 
develop and 
implement a 
severity scoring 
system for SSTI’s 
and to identify 
factors 
contributing to 
treatment failure.  
 
N=  
Study A-  632 
Study B- 334 
 
n= 
 A- 133  
 B- 38 
 
M age=  
A-16.8 
B-49.2 
 
C= 
A- 56.8% 
B- 88.5% 
M= 
A-63% 
B-46.9% 
IV1= 
Comorbidities 
 
IV2=BUN 
 
IV3= Sodium 
 
IV4= Hematocrit 
 
IV5= Lesion size 
 
IV6= Surgical 
wound infection  
 
IV7=Linezolid 
intervention 
IV8= Comparator 
group 
IV1-IV7= 
Modified 
Fine Severity 
Scoring 
Model  
IV2= >30 
IV3= <130 
IV4= <30% 
IV5= <150cm 
 
DV1= 
measured by 
number of 
days/number 
of doses of 
treatment 
until s/sx 
improved.  
Logistic 
Regression  
 
P= <0.05 
IV1= 
P= <0.1 
 
IV2=  
P= 0.023* 
 
IV3=  
P= 0.036* 
 
IV4=  
P= 0.002* 
 
IV5=  
P= 0.009* 
 
IV6=  
P= 0.039* 
 
LOE: Level II 
 
W: Study criteria 
excluded 
uncomplicated 
SSTI’s, 
necrotizing 
fasciitis and 
diabetic foot 
ulcers. Not all 
variables 
included that 
could influence 
outcome in 
severity scale. 
Only applied to 
hospital 
population, not 
SKIN AND SOFT TISSUE INFECTIONS  
 
 
A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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companies 
which may 
influence their 
recommendatio
ns on the use of 
antimicrobial 
therapy 
 
Country: USA 
 
 
 
 
SS= 
A- 133 sites 
in USA, 
Latin 
America, 
Asia 
B- 38 sites 
in 
Europe, 
South 
Africa 
 
IC= hospitalized, 
Gram + 
complicated SSTI, 
signed consent 
form 
 
EC= 
Uncomplicated 
SSTI, Outpatient 
setting, Other 
organisms besides 
Gram + 
 
DV1= Lower 
Clinical Cure Rate 
 
Complicated 
Definition: 
infections 
extending into the 
deeper tissue and 
requiring systemic 
antibiotic therapy 
and surgical 
interventions 
 
Clinical Cure 
definition: 
Resolution of 
baseline s/sx of 
infection or 
improvement after 
at least 5 days and 
20 doses of study 
medication. 
 
Clinical Failure 
definition:  
Persistence or 
progression of s/sx 
of infection after at 
least 2 days and 8 
IV7=  
P= 0.001* 
 
IV8- Not 
significant 
 
DV1=  
P=0.001* 
 
Findings: 
Comorbidities 
significantly 
decrease cure 
rate. BUN, 
sodium, 
hematocrit, 
lesion size and 
presence of 
surgical wound 
infection are 
clinically 
significant 
factors in clinical 
cure rates. 
Clinical cure 
rates were lower 
in patients who 
disease scores 
below the 
median and who 
primary care.  
 
S: Large SS, 
Level II evidence 
 
APP: This 
scoring tool 
provides a 
practical tool for 
assessing 
patients with 
complicated 
SSTI’s and 
identifying those 
who may need 
more aggressive 
support. This 
scoring system 
can be used as an 
overall guide to 
overall prognosis 
and to the level 
of 
medical/surgical 
treatment.  
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A: age, AA: African American, ABSSI: Acute bacterial skin and skin structure infections, ADL: activities of daily living, AGR: age range, AHRQ: Agency for research healthcare and quality, APP: 
application, BSA: Body surface area, C: Caucasian, CA: cellulitis/abscess, CA-MRSA: Community acquired Methicillin resistant staphylococcus aureus, CCR: Clinical cure rate, CF: correctional 
facility/facilities, CI: Confidence interval, CM: Co-morbidity, CR: Complete response, CR%: Caucasian race percentage, DAT: days of antibiotic therapy, DIA: Delayed Initiation antibiotics, DS: 
Duration of symptoms, DT: Duration of therapy, DV: dependent variable, E: ethnicity, EC: exclusion criteria, ED: emergency department, ESM: Economic Simulation Model, F: female, FE: 
Feasibility, G: gender, H: Hispanic, HCUP: healthcare cost and utilization project, HOW: history of wound,  IC: inclusion criteria, I&D: incision and drainage, IPT: Inpatient treatment, IV: 
independent variable, KPNC: Kaiser Permanente of Northern California, LHS: Length of hospital stay, LOA: lack of adherence, LOE: Level of evidence, M: male, MA: Metanalysis, M Age: Mean 
age, MIDAS: Models of Infectious Disease Agent Study, MOR: Mortality, n: sample size studies, ME: Median, N: sample size cases/people, MRSA: Methicillin resistant staphylococcus aureus, NF: 
necrotizing fasciitis, NI: Not identified in article, NIS: nationwide inpatient sample,, NWC: Negative wound culture, O: Obese, OP: outpatient, OPT: Outpatient treatment, OT: Over treatment, PC: 
participant characteristics, PWC: Positive wound culture, PRTM: Predictive risk tool model, PCS: Prospective cohort study, RCS: Retrospective cohort study, REH: Re-hospitalization, RR: 
Reference range, RSST: Risk severity stratification tool, SA: staphylococcus areus, SABSSSI: Severity of acute bacterial skin and skin structure infections, SI: site of infection, SEWS: Standardized 
early warning score, SIRS: systemic inflammatory response syndrome, SR: Systematic Review, SS: Number of study sites, SS: Severity of SSTI, S/S: Signs/symptoms, SSTI’s: Skin and soft tissue 
infections, STP: standardized treatment plan, TF: treatment failure, TS: type of SSTI, UK: United Kingdom, USA: United States of America,  UT: Under treatment, VS: Vital signs abnormalities, 
WBC: white blood cell count, WS: Wound size, Y: years, $: US dollars,  $$: US dollars in Millions,   
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doses of 
medication 
were in the high-
risk classes. 
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CREST: Clinical resource efficiency support team, N: sample size, SEWS: Standardized early warning score, SSTI’s: skin and soft tissue infections, *: Statistically significant  
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Appendix E 
Synthesis Table:  Severity/Risk Stratification Scales in SSTI’s 
  Author  
  
Figtree 
 
Hashem 
 
Jenkins 
 
 
Lane 
 
Lee 
 
Marwick 
 
Marwick 
 
Talan 
 
Tiwari 
 
Wilson 
 Study Characteristics   
Year: 2012 2016 2011 2016 2016 2011 2012 2014 2014 2011 
Design:           
Retrospective Cohort  X X X   X     
Prospective Cohort      X  X X X X 
Cross Sectional    X       
           
Setting:           
Community   X X X     X 
Inpatient  X X X X  X X X X X 
 Population Demographics  
Sample:           
Number of sites 1 1 1 N/A 14 2 2 12 1 133, 38 
N 395 200 344 400 106 79 79 619 105 632, 334 
           
Duration  7 y 1 y 2 y NI NI 15 
Months 
15 months NI NI NI 
Demographics:        *   
 Age (mean)  70.6 54 CO-46 
I- 47 
USA-45 
UK-42 
41 AGR-37- 
69 
52 38.7 41.2 16.8, 49.2 
Male Gender (%)  43% 53% CO- 75% 
I- 66% 
USA-64.5% 
UK- 70% 
50% 65% 65% 57.5% 83.81% 63%, 46.9% 
           
Tools used:            
Risk severity 
stratification tool 
X     X   X X 
Standardized treatment 
plan 
  X        
CREST  X    X X    
SEWS  X    X     
Severity of acute 
bacterial SSTI’s 
   X       
Ki/Rotstein       X X    
SKIN AND SOFT TISSUE INFECTIONS IN HIGH RISK POPULATIONS 
CREST: Clinical resource efficiency support team, N: sample size, SEWS: Standardized early warning score, SSTI’s: skin and soft tissue infections, *: Statistically significant  
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Systemic 
inflammatory response 
syndrome 
     X     
Charlson Index      X     
  Independent Variables  
Age X*   X*  X*  X*   
Co-Morbidities X*   X*  X* X X*  X 
Duration of symptoms X*    X*      
S/SX  X*  X*   X X*   
Wound Size X*    X*   X* X* X* 
Vital signs        X* X*  
  Measurable Outcomes  
Length of hospital stay X  X X       
Complete response  X     X   X 
Duration of therapy   X        
Re-hospitalization rate X  X X   X    
Outpatient treatment    X    X   
SKIN AND SOFT TISSUE INFECTIONS IN HIGH RISK POPULATIONS 
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Appendix F 
The Advancing Research and Clinical Practice Through Close Collaboration (ARCC) EBP Model  
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